Free Trial

Matt Larew - William Blair Analyst Performance

This page shows the methodology used to calculate Matt Larew's recommendation performance. Listed below are links to the research notes issued, the price targets issued by the analyst, and the stock's actual price 12 months from the date the research note was issued. These rankings are based on research reports from . Rankings are updated daily.

MarketBeat Analyst Ranking:
Average 12-Month ROI of Buy and Strong Buy Recommendations: ???%

CompanyReport DateReport Date Price12-Month
Price Target
Rating12-Month
Actual Price
12-Month
ROI
Details
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
8/18/2025$488.15Outperform???%???%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
8/7/2025$2.04Market Perform???%???%
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
3/17/2020$59.24Hold???%???%
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
1/31/2020$117.14Buy???%???%
DaVita Inc. stock logo
DVA
DaVita
9/11/2019$61.66Market Perform???%???%
DaVita Inc. stock logo
DVA
DaVita
6/20/2019$52.42Buy???%???%
Labcorp Holdings Inc. stock logo
LH
Labcorp
12/3/2018$145.08Buy???%???%
LHC Group, Inc. stock logo
LHCG
LHC Group
11/1/2018$86.75Buy???%???%
DaVita Inc. stock logo
DVA
DaVita
6/6/2018$67.32Buy???%???%
LHC Group, Inc. stock logo
LHCG
LHC Group
5/6/2018$71.56Buy???%???%


Return to Analyst Rankings